Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Combining Serum PVT1 Exon 4A and Exon 9 with Serum Prostate-Specific Antigen Shows Potential for Improving Identification and Risk Stratification of Prostate Cancer
Saved in:
| Published in: | Cancer Management and Research |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Combining Serum PVT1 Exon 4A and Exon 9 with Serum Prostate-Specific Antigen Shows Potential for Improving Identification and Risk Stratification of Prostate Cancer
- Identification of serum protein biomarkers for pre‐cancerous lesions associated with pancreatic ductal adenocarcinoma
- PET-MR Examination in Diagnosing Bone Metastases in Prostate Cancer
- Oncolytic adenovirus Ad657 for systemic virotherapy against prostate cancer
- PARP inhibition and pharmacological ascorbate demonstrate synergy in castration‐resistant prostate cancer
- Immune Cell Infiltration and Causal Relationships with Prostate Cancer: A Transcriptomic and Mendelian Randomization Study
- Serum ATIC Expression as a Novel Diagnostic and Prognostic Biomarker in Multiple Myeloma Patients